-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Core Scientific, Raises Price Target to $29

Benzinga·04/09/2026 15:04:01
Listen to the news
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and raises the price target from $25 to $29.